Effect of rosiglitazone, compared to sulphonylurea, on endothelial function in Chinese patients with type two diabetes
Phase of Trial: Phase II
Latest Information Update: 01 Dec 2007
At a glance
- Drugs Rosiglitazone (Primary) ; Glibenclamide; Gliclazide; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 25 Apr 2007 New trial record.